A signal-processing–based framework converts DNA sequences into numerical signals to identify protein-coding regions. By integrating spectral analysis and SVM classification, the approach improves ...

Researchers reckon it could dramatically accelerate understanding of how DNA influences disease, cancer, and drug discovery.

A deep learning framework combines convolutional and bidirectional recurrent networks to improve protein function prediction from genomic ...

Yes, I would like to be contacted by a representative to learn more about Bloomberg's solutions and services. By submitting this information, I agree to the privacy policy and to learn more about ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A trio of investors helped a New ...

After taking a shot at becoming a neuroscience biotech, buzzy Bay Area AI outfit Verge Genomics is dropping its only clinical asset and returning to its drug discovery roots. The decision comes after ...

Researchers at The University of Texas MD Anderson Cancer Center have performed a comprehensive evaluation of five artificial intelligence (AI) models trained on genomic sequences, known as DNA ...

CARLSBAD, Calif.--(BUSINESS WIRE)--Arima Genomics, Inc., a company leveraging whole-genome sequence and structure information to provide comprehensive cancer therapy selection insights, today ...

Seed plants are essential as a source of food, fuel, medicine, and more. Now, a multidisciplinary team of researchers has combined deep botanical knowledge with powerful genomic technology to decode ...

CORONA, Calif., Nov. 10, 2025 /PRNewswire/ -- The DNA Company, a global leader in functional genomics and personalized health, has been named Functional Genomics Innovation of the Year in the 2025 ...